Cargando…
Protective Ability of Biogenic Antimicrobial Peptide Microcin J25 Against Enterotoxigenic Escherichia Coli-Induced Intestinal Epithelial Dysfunction and Inflammatory Responses IPEC-J2 Cells
Poison of intestinal induce severe health problems in human infants and young animals due to contaminating foods and feedstuffs. With the emergence of public health concerns and high-speed diffuse of drug-opposition of bacteria, the adoption of antimicrobial peptides as potential candidates in treat...
Autores principales: | Yu, Haitao, Ding, Xiuliang, Shang, Lijun, Zeng, Xiangfang, Liu, Hongbin, Li, Ning, Huang, Shuo, Wang, Yuming, Wang, Gang, Cai, Shuang, Chen, Meixia, Levesque, Crystal L., Johnston, Lee J., Qiao, Shiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053529/ https://www.ncbi.nlm.nih.gov/pubmed/30057893 http://dx.doi.org/10.3389/fcimb.2018.00242 |
Ejemplares similares
-
Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic Escherichia coli-Challenged Mouse Model
por: Ding, Xiuliang, et al.
Publicado: (2020) -
Effect of Antimicrobial Peptide Microcin J25 on Growth Performance, Immune Regulation, and Intestinal Microbiota in Broiler Chickens Challenged with Escherichia coli and Salmonella
por: Wang, Gang, et al.
Publicado: (2020) -
A Comprehensive Antimicrobial Activity Evaluation of the Recombinant Microcin J25 Against the Foodborne Pathogens Salmonella and E. coli O157:H7 by Using a Matrix of Conditions
por: Yu, Haitao, et al.
Publicado: (2019) -
Biosynthetic Microcin J25 Exerts Strong Antibacterial, Anti-Inflammatory Activities, Low Cytotoxicity Without Increasing Drug-Resistance to Bacteria Target
por: Yu, Haitao, et al.
Publicado: (2022) -
Engineering and Purification of Microcin C7 Variants Resistant to Trypsin and Analysis of Their Biological Activity
por: Yang, Guangxin, et al.
Publicado: (2023)